United States· US:30698-452_4b9222f7-7b31-4781-e063-6394a90ab188

Lotensin HCT

A medicinal product containing benazepril hydrochloride; hydrochlorothiazide, registered in United States by Validus Pharmaceuticals LLC.

US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedLotensin HCTATC—REGISTER NO.US:30698-452_4b9222f7…PACKS LISTED2CHECKEDSeptember 27, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
Manufacturer
Validus Pharmaceuticals LLC
Country
United States (US)
ATC code
—
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    30698-452-01
  • ndc11
    3069845201
    100 TABLET in 1 BOTTLE (30698-452-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Benazepril hydrochloride; hydrochlorothiazide in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benazepril hydrochloride; hydrochlorothiazide products

Authorised across Europe · EMA

The same active substance is authorised in 6 EEA countries. Names it is sold under:

  • Germany · Benazeplus, Benazepril Comp 1 A Pharma
  • France · Benazepril Hydrochlorothiazide Eg, Benazepril/Hydrochlorothiazide Arrow
  • Greece · Cibadrex
  • Hungary · Lotensin Hct
  • Italy · Benazepril Idroclorotiazide Eg, Benazepril Idroclorotiazide Sandoz
  • Netherlands · Benazepril Hcl/Hydrochloorthiazide Hexal Ag

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e89aa18c-ffa5-48a9-9d3e-8ff521f1d47c
GET /v1/drugs/e89aa18c-ffa5-48a9-9d3e-8ff521f1d47c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "10; 12.5",
  "substance": "BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE",
  "productndc": "30698-452",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "strength_unit": "mg/1; mg/1",
  "application_number": "NDA020033",
  "marketing_category": "NDA"
}

See everything about benazepril hydrochloride; hydrochlorothiazide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.